Clinical trials in Hodgkin lymphoma

The table below shows a list of The Lymphoma Group's current clinical trials open for recruitment for Hodgkin lymphoma patients.

 

Please note: The link for more information on the trials below is currently not operating. Apologies for this inconvenience while we try to fix the problem. In the meantime please get in touch via our email lymphomaclinicaltrials@christie.nhs.uk and we can provide you with more information on the trial.

 

 

Trial Name

 

Description

 

Click for more information (external page) LINK BROKEN

 

ADCT-301

 

A phase 1 study testing a new drug, ADCT-301

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

MK-3475-204

 

Phase 3 study of of Pembrolizumab (MK-3475) vs. Brentuximab Vedotin.

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

*Please note, we update this page fortnightly

With special thanks to the following:

;